Mill Creek Capital Advisors LLC increased its holdings in shares of The Procter & Gamble Company (NYSE:PG – Free Report) by 0.2% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 112,080 shares of the company’s stock after purchasing an additional 253 shares during the quarter. Procter & Gamble makes up about 0.5% of Mill Creek Capital Advisors LLC’s investment portfolio, making the stock its 24th biggest holding. Mill Creek Capital Advisors LLC’s holdings in Procter & Gamble were worth $18,790,000 at the end of the most recent quarter.
Several other large investors have also added to or reduced their stakes in the business. Concurrent Investment Advisors LLC boosted its stake in shares of Procter & Gamble by 4.5% in the 3rd quarter. Concurrent Investment Advisors LLC now owns 94,109 shares of the company’s stock valued at $16,300,000 after purchasing an additional 4,035 shares in the last quarter. Copley Financial Group Inc. bought a new position in Procter & Gamble in the 3rd quarter valued at approximately $668,000. Fortem Financial Group LLC bought a new position in Procter & Gamble in the 4th quarter valued at approximately $569,000. Nordea Investment Management AB raised its holdings in Procter & Gamble by 7.5% in the 4th quarter. Nordea Investment Management AB now owns 2,898,569 shares of the company’s stock valued at $484,583,000 after buying an additional 201,695 shares during the last quarter. Finally, Synovus Financial Corp raised its holdings in Procter & Gamble by 3.4% in the 3rd quarter. Synovus Financial Corp now owns 185,134 shares of the company’s stock valued at $32,065,000 after buying an additional 6,077 shares during the last quarter. Institutional investors and hedge funds own 65.77% of the company’s stock.
Procter & Gamble Stock Down 0.3 %
Shares of NYSE PG opened at $167.45 on Tuesday. The Procter & Gamble Company has a 12 month low of $153.52 and a 12 month high of $180.43. The company has a current ratio of 0.76, a quick ratio of 0.55 and a debt-to-equity ratio of 0.50. The firm has a market capitalization of $392.64 billion, a price-to-earnings ratio of 26.66, a PEG ratio of 3.79 and a beta of 0.45. The business has a 50-day moving average of $167.30 and a 200-day moving average of $169.43.
Procter & Gamble Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, February 18th. Stockholders of record on Friday, January 24th will be paid a dividend of $1.0065 per share. This represents a $4.03 dividend on an annualized basis and a dividend yield of 2.40%. The ex-dividend date is Friday, January 24th. Procter & Gamble’s dividend payout ratio (DPR) is presently 64.17%.
Insider Activity at Procter & Gamble
In related news, CEO Gary A. Coombe sold 47,847 shares of the stock in a transaction on Wednesday, November 27th. The stock was sold at an average price of $179.84, for a total transaction of $8,604,804.48. Following the sale, the chief executive officer now directly owns 39,977 shares of the company’s stock, valued at $7,189,463.68. This trade represents a 54.48 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider Marc S. Pritchard sold 90,450 shares of the stock in a transaction on Thursday, January 23rd. The shares were sold at an average price of $163.84, for a total value of $14,819,328.00. Following the sale, the insider now directly owns 172,814 shares in the company, valued at $28,313,845.76. This trade represents a 34.36 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 151,097 shares of company stock worth $25,635,076 over the last quarter. 0.18% of the stock is owned by corporate insiders.
Analysts Set New Price Targets
Several research analysts have issued reports on the stock. Stifel Nicolaus raised their price target on shares of Procter & Gamble from $161.00 to $165.00 and gave the stock a “hold” rating in a report on Thursday, January 23rd. Evercore ISI lifted their price objective on shares of Procter & Gamble from $180.00 to $183.00 and gave the company an “outperform” rating in a research note on Monday, October 21st. Morgan Stanley lifted their price objective on shares of Procter & Gamble from $174.00 to $191.00 and gave the company an “overweight” rating in a research note on Monday, October 21st. JPMorgan Chase & Co. lowered their price objective on shares of Procter & Gamble from $186.00 to $181.00 and set an “overweight” rating for the company in a research note on Thursday, January 16th. Finally, DA Davidson reissued a “buy” rating and issued a $209.00 price target on shares of Procter & Gamble in a research report on Thursday, January 23rd. Eight research analysts have rated the stock with a hold rating, thirteen have given a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $180.53.
Get Our Latest Research Report on PG
Procter & Gamble Company Profile
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Further Reading
- Five stocks we like better than Procter & Gamble
- Investing in the High PE Growth Stocks
- Merck: 4 No-Brainer Reasons to Buy This Dip
- How to Start Investing in Real Estate
- Ackman Announces Major Stake in Uber: Should You Follow His Lead?
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- Wells Fargo Upgraded These 3 Stocks—Here’s Why They Stand Out
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.